¿Oasis? Caifanes mejor
🗣️🇲🇽Y VIENES DESDE ALLÁ
DONDE NO SALE EL SOL
DONDE NO HAY CALOR
DONDE LA SANGRE NUNCA
SE SACRIFICÓ POR UN AMOR
PERO AQUÍ
NO ES ASÍ 🇲🇽🗣️
Inglaterra conocerá México
difícil ganar, pero… ¿Y SI SÍ?
1/10 🚨 Excited to share our new multicenter study in CKJ. https://t.co/dPVDIcgHn7
What if “urgent-start PD” is actually… too slow? 👀
We found that many patients can safely start peritoneal dialysis within HOURS of catheter placement, not days. 🇲🇽🩺
a thread 🧵
#Nephtwitter#MedEd
Sx CR1🫀🫘 y TRR 🤔
✔️Congestión persistente razón principal de iniciar TRR - Resistencia diurética de las principales razones
✔️Importante evaluación de la descongestión 👀
✔️Beneficios de UF/TRR 👀
Revisión🔝
Villegas-Gutiérrez et al. Cardiorenal Med. 2024
It is an honor for me to have been considered by @NatRevNeph to give my point of view on pregnancy with advanced kidney disease. I share the link with you in case you want to read it and help me share.@INPer_mx
La barrera de filtrado glomerular es una red de proteínas que interactúan perfectamente, cuando existen anticuerpos contra alguno de sus componentes, como los antineferina, se disrumpe dando lugar a proteinuria y progresión del daño
NEJM 2024
10.1056/NEJMe2404974
1/ 🚨 📢 Tweetorial Alert !
👋Hey #NephTwitter, today let's discuss Thrombotic microangiopathy (TMA) in pregnancy from the recently published wonderful review in @KIReports
🌟https://t.co/Q1188vPz4H by
@ManuelUrra7@RichardBurwick @CTeodosiu @anuja_java
Microangiopatias tromboticas y el RIÑÓN 🫘
▪️SHUa, secundario a💊, Infecciosa🦠, asociado a 🤰🏻, inmunomediada, asociada a CA, asociada a trasplante
🟠TX liq-electrolitos+ TSR +transfusiones + TX infección
🟠Inh C5 ➡️Eculizumab/ravulizumab
AKHD 2024
https://t.co/upjpVQLgNu
Early-onset lupus nephritis
https://t.co/EF89rbtzaK
This Review focuses on the clinical & histological aspects of early-onset LN aiming at highlighting relevant differences with adult patients emphasizing long-term outcomes & discussing the management of long-term complications
DNAJB9 Is a Specific Immunohistochemical Marker for Fibrillary Glomerulonephritis ca. 2017 from @KIReports#Nephpearls#VisualAbstract by @whatsthegfr
👉 https://t.co/WfJVs4OocN
👉 https://t.co/MpPdIGZE0c
Cambios micro-macroscópicos en el riñón asociados a la edad.
Excelente revisión de Nature. Estamos en la era de la nefro geriatría. 👵🏻👴🏼🫘
Treatment of chronic kidney disease in older populations.
https://t.co/6ry7BTr5nb.
https://t.co/Ki3frjrLot
Management of the Hemodialysis Patient with Catheter-Related Bloodstream (CRBSI) Infection ca. 2019 from @CJASN @nephrogeek1#Nephpearls
👉🏼 https://t.co/VTt32zsclp
👇🎯lupus nephritis in pregnancy
✅Continue HCQ
🔥Start ecosprin 10-14wk
🦋Stop ACEi/ARB
👐Ds should be well controlled atleast 6 months prior
Monitor for aPLs/Anti Ro
⏬Flare of LN in pregnancy 🤰
https://t.co/s0jI6KwrNo
Amyloidosis, a systemic disease that manifests in various ways, should be in the differential diagnosis of unexplained proteinuria, restrictive cardiomyopathy, peripheral and autonomic neuropathy, and hepatomegaly. Treatments are improving. Full review: https://t.co/vlStjJWraz
ROL del COMPLEMENTO en enfermedades glomerulares🫘
⛔️NM, N IgA, LES, C3G, ANCA-V, SHU-A (img 1.)
▪️Enf en las que impactan más la ❌C’➡️C3G,SHUa, MPGN 1a (img 2.)
▪️¿IgA, ANCA-V, NM, FSGS, DKD?
▪️TX potenciales(img 3.)
KIDNEY INTERNATIONAL 2024
https://t.co/mnGQwWHX4Z